RxDoctor Payments Data

Andy Roberts, MD

Family Medicine · Greeneville, TNNPI 1013900943

Payments from drug & device makers

$395in general payments, 2019–2025

Across 21 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109
  • Phathom Pharmaceuticals, Inc.$83
  • Novo Nordisk$68
  • Johnson & Johnson$18
  • Abbott$18
  • Boehringer Ingelheim$17
  • plus $82 from 6 others

What the payments were for

  • Food & beverage$395100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$395 in reported general payments places this provider in the 45th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$128,231
Medicare patients
260
Services billed
2,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban136$124,306
MounjaroTirzepatide67$96,924
JardianceEmpagliflozin39$50,497
XareltoRivaroxaban55$48,014
TrulicityDulaglutide29$41,737
RybelsusSemaglutide22$32,770
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$30,452
Tresiba Flextouch U-200Insulin Degludec20$17,708
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog17$16,161
JanuviaSitagliptin Phosphate12$15,305
LinzessLinaclotide20$13,231
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$9,784
Emgality PenGalcanezumab-Gnlm12$7,971
Combivent RespimatIpratropium/Albuterol Sulfate15$7,002
SymbicortBudesonide/Formoterol Fumarate22$5,595

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$14$138,66196 claims
Boehringer IngelheimJardiance, Combivent Respimat$17$57,49954 claims
Johnson & JohnsonXarelto$18$48,01455 claims
Novo NordiskRybelsus$68$32,77022 claims
AbbVieLinzess$109$13,23120 claims
AstraZenecaSymbicort$15$5,59522 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Greeneville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →